Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
MEVACOR
Generic name / active ingredient
lovastatin
Dosage-form class
Historical MEVACOR products and the current generic comparator are conventional lovastatin oral tablets. ALTOPREV is an extended-release lovastatin tablet under a different NDA, while ADVICOR also contains niacin. Conventional, extended-release and combination products must not be conflated, assembled or substituted from a brand name or total milligrams
Route
Oral
Record reviewed
2026-08-30

Copy from the pack in hand

Source-linked reading points

  • Clarithromycin, itraconazole, ketoconazole and other strong CYP3A inhibitors create important interaction boundaries with lovastatin. Other medicines may also require review. Do not self-separate times, reduce, stop or continue from this page; have the prescribing team or pharmacist check all prescription, OTC and supplement products.
  • Unexplained muscle pain, tenderness, cramps or weakness, especially with marked fatigue, fever or dark urine, may need prompt assessment. Use local emergency services for severe or rapidly worsening signs rather than waiting for a webpage to decide whether rhabdomyolysis is present.
  • Pregnancy, possible pregnancy, pregnancy planning or breastfeeding requires prompt review of the current label and clinical plan. Do not self-continue, stop, use alternate days or switch statins from a historical label or webpage.
  • Historical MEVACOR 10/20/40 mg and the current 40 mg generic comparator are conventional-tablet identities. ALTOPREV is extended-release and ADVICOR also contains niacin. Form, ingredients, strength, NDA/ANDA, NDC and target market must be checked together.

Reviewed presentation examples — compare every field

  • Lovastatin 10 mg per tablet; currently listed by FDA as DISCNNDA 019643 / product 002
  • Lovastatin 20 mg per tablet; currently listed by FDA as DISCNNDA 019643 / product 003
  • Lovastatin 40 mg per tablet; currently listed by FDA as DISCNNDA 019643 / product 004
  • Lovastatin 40 mg per tablet; 1,000-tablet bottle; ANDA 075991 generic comparatorNDC 43063-548-95

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-30
Source record
4 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image